NCT05936281View on ClinicalTrials.gov

A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)

PHASE2CompletedINTERVENTIONAL

Enrollment

165

Participants

Timeline

Start Date

July 20, 2023

Primary Completion Date

January 19, 2024

Study Completion Date

January 19, 2024

Conditions

GoutGout Initiating Urate-loweringUrate-lowering Therapy

Interventions

DRUG

Genakumab for injection

150 mg/1ml/ vial

DRUG

Colchicine

0.5 mg/table

Trial Locations (1)

200030

Fudan University Affiliated Huashan Hospital, Shanghai

All Listed Sponsors

collaborator

Huashan Hospital

OTHER

lead

Changchun GeneScience Pharmaceutical Co., Ltd.

INDUSTRY

NCT05936281 - A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202) | Biotech Hunter | Biotech Hunter